Diabetic retinopathy clinical pearl pictorial

Publication
Slideshow
Optometry Times JournalNovember digital edition 2020
Volume 12
Issue 11

Trace the path of diabetic retinopathy disease via images.

Retinal (macular) edema is caused by the breakdown of the blood-retinal barrier, resulting in leakage of serum, lipids and protein.

On clinical examination, edema may be difficult to see, but vascular changes such as microaneurysms and hard lipids known as exudates are often better visible (Figure 1A).

Related: Patient perception of good vision a trap leading to loss

On optical coherence tomography (OCT), edema results in variable increases in the retinal or macular thickness, and fluid is often represented as hypo-reflective pockets (Figure 1B).

Following successful treatment with anti-vascular endothelial growth factor (VEGF) injections and/or laser photocoagulation, an increase in hard exudates may initially be noted as serum dries out while hard lipid residue forms (Figures 2A and 2B).

Related: Know the many facets of diabetic retinopathy

Once the leakage stops, it may take several months for the hard exudates—seen as intraretinal hyper-reflective deposits on the OCT—to slowly absorb (Figure 3).

Occasionally, the solidifying serum can be seen in mid-phase from liquid to hard deposits. This can be referred to as “soft exudate,” not to be confused with the use of the same term to describe cotton-wool spots. Clinically, “soft exudate” has a creamy color (Figure 4A); on OCT it has a semi hyper-reflective presentation (Figure 4B). After treatment, this material turns to hard exudate and dissipates over time (Figures 5 and 6).

Related: Retina presentation looks familiar

Neglecting continued care of the disease can result in significant worsening of these findings and patients prognosis (Figure 7).

The patient depicted here failed to return for continued treatment for several months, resulting in increased severity of exudative retinopathy.

Related: Time in range as an alternative to HbA1c

Recent Videos
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses diagnostic confusion that can be encountered when identifying macular edema in patients.
Dr. Jeffry Gerson, OD, FAAO, gave a presentation on diabetes at AAO 2024
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Mohammad Rafieetary, OD, FAAO
Dr. Mohammad Rafieetary
© 2024 MJH Life Sciences

All rights reserved.